These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 3308217
1. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Brett SJ, Kingston AE, Colston MJ. Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217 [Abstract] [Full Text] [Related]
2. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Shankar P, Agis F, Wallach D, Flageul B, Cottenot F, Augier J, Bach MA. J Immunol; 1986 Jun 01; 136(11):4255-63. PubMed ID: 2422278 [Abstract] [Full Text] [Related]
3. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG. Int J Lepr Other Mycobact Dis; 1993 Mar 01; 61(1):51-8. PubMed ID: 8326181 [Abstract] [Full Text] [Related]
4. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH. J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851 [Abstract] [Full Text] [Related]
5. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ, Closs O, Belehu A. Int J Lepr Other Mycobact Dis; 1982 Dec 15; 50(4):455-67. PubMed ID: 6763003 [Abstract] [Full Text] [Related]
6. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Ottenhoff TH, Converse PJ, Gebre N, Wondimu A, Ehrenberg JP, Kiessling R. Eur J Immunol; 1989 Apr 15; 19(4):707-13. PubMed ID: 2659369 [Abstract] [Full Text] [Related]
7. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Kaleab B, Ottenoff T, Converse P, Halapi E, Tadesse G, Rottenberg M, Kiessling R. Eur J Immunol; 1990 Dec 15; 20(12):2651-9. PubMed ID: 2269329 [Abstract] [Full Text] [Related]
8. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS. Int J Lepr Other Mycobact Dis; 1996 Sep 15; 64(3):257-67. PubMed ID: 8862259 [Abstract] [Full Text] [Related]
9. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy. Nath I, Sathish M, Jayaraman T, Bhutani LK, Sharma AK. Clin Exp Immunol; 1984 Dec 15; 58(3):522-30. PubMed ID: 6391762 [Abstract] [Full Text] [Related]
10. Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD. Smelt AH, Liew FY, Rees RJ. Clin Exp Immunol; 1978 Nov 15; 34(2):164-9. PubMed ID: 367652 [Abstract] [Full Text] [Related]
11. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy. Nath I, Singh R. Clin Exp Immunol; 1980 Sep 15; 41(3):406-14. PubMed ID: 7002396 [Abstract] [Full Text] [Related]
12. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin. Barnass S, Mace J, Steele J, Torres P, Gervasoni B, Ravioli R, Terencio J, Rook GA, Waters MF. Clin Exp Immunol; 1986 Apr 15; 64(1):41-9. PubMed ID: 2426020 [Abstract] [Full Text] [Related]
13. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. Kaplan G, Gandhi RR, Weinstein DE, Levis WR, Patarroyo ME, Brennan PJ, Cohn ZA. J Immunol; 1987 May 01; 138(9):3028-34. PubMed ID: 3106496 [Abstract] [Full Text] [Related]
14. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2. Mohagheghpour N, Gelber RH, Larrick JW, Sasaki DT, Brennan PJ, Engleman EG. J Immunol; 1985 Aug 01; 135(2):1443-9. PubMed ID: 2989366 [Abstract] [Full Text] [Related]
15. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation. Bjune G. Int J Lepr Other Mycobact Dis; 1978 Aug 01; 46(3-4):386-93. PubMed ID: 83309 [Abstract] [Full Text] [Related]
16. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Gulle H, Schoel B, Chiplunkar S, Gangal S, Deo MG, Kaufmann SH. Int J Lepr Other Mycobact Dis; 1992 Mar 01; 60(1):44-53. PubMed ID: 1602193 [Abstract] [Full Text] [Related]
17. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients. Bach MA, Wallach D, Flageul B, Cottenot F. Clin Exp Immunol; 1983 Apr 01; 52(1):107-14. PubMed ID: 6345031 [Abstract] [Full Text] [Related]
18. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w. Mustafa AS. Int J Lepr Other Mycobact Dis; 1988 Jun 01; 56(2):265-73. PubMed ID: 3045224 [Abstract] [Full Text] [Related]
19. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test. Job CK, Chacko CJ, Taylor PM, Daniel M, Jesudian G. Int J Lepr Other Mycobact Dis; 1976 Jun 01; 44(1-2):256-66. PubMed ID: 776862 [Abstract] [Full Text] [Related]
20. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Chattree V, Khanna N, Rao DN. Mol Immunol; 2007 Mar 01; 44(8):2066-77. PubMed ID: 17046060 [Abstract] [Full Text] [Related] Page: [Next] [New Search]